Elliot A. Asare
( out of 157 reviews )

Elliot A. Asare, MD, MS, CMQ, FACS

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

801-587-8808

  • Elliot Asare, MD, MS is an Assistant Professor in the Section of Surgical Oncology within the Division of General Surgery at the University of Utah. Dr. Asare specializes in cutaneous malignancies and sarcomas of the retroperitoneum and other soft tissues.

    Dr. Asare is a Phi Beta Kappa graduate of Randolph-Macon College in Ashland, Virginia where he was a double major in Chemistry and Biology. He subsequently received his medical education at Howard University College of Medicine, Washington, DC and was inducted into the Alpha Omega Alpha Medical Honors Society. He had his General Surgery residency training at the Medical College of Wisconsin Affiliated Hospitals in Milwaukee, WI. Dr. Asare served as a clinical scholar-in-residence with the American Joint Committee on Cancer (AJCC) during residency. He has a masters degree in health services and outcomes research from Northwestern University, Chicago, IL. Following residency, he trained in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center, Houston, TX.


    Dr. Asare’s research interests include improving cancer data quality, cancer staging, prognostication, surveillance, clinical trials and outcomes research. He practices both at the Huntsman Cancer Institute and Intermountain Healthcare Center in Murray.

    Specialties

    Board Certification

    American Board of Surgery (Sub: Complex General Surgical Oncology)
    American Board of Surgery (Sub: General Surgery)

    Patient Rating

    4.9 /5
    ( out of 157 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 16, 2023
    HUNTSMAN CANCER CENTER

    Dr. Asare is very caring with his patient's well being and their family members who are there to support them. He is amazing!!

    September 03, 2023
    HUNTSMAN CANCER CENTER

    Dr. Asare is very friendly and courteous towards me. He will explain anything I ask.

    August 20, 2023
    HUNTSMAN CANCER CENTER

    Very Thorough and Compassionate

    August 19, 2023
    HUNTSMAN CANCER CENTER

    I am glad he is my doctor.

    August 19, 2023
    HUNTSMAN CANCER CENTER

    Took the time to explain things carefully, drawing some simple sketches to help to explain things ( Which did help a lot)

    August 06, 2023
    HUNTSMAN CANCER CENTER

    Extremely professional, explained in detail my upcoming surgery and the results of my biopsy. A gentleman surgeon. Feel confident that he is taking care of me.

    August 06, 2023
    HUNTSMAN CANCER CENTER

    My interactions with Dr. Asare, before, during and after my surgery were totally positive. I have the utmost confidence in him.

    August 05, 2023
    HUNTSMAN CANCER CENTER

    I believe Dr Asare saved my life and he is very compassionate

    August 05, 2023
    HUNTSMAN CANCER CENTER

    He is professional, calm

    See More Patient Comments

  • Elliot Asare, MD, MS is an Assistant Professor in the Section of Surgical Oncology within the Division of General Surgery at the University of Utah. Dr. Asare specializes in cutaneous malignancies and sarcomas of the retroperitoneum and other soft tissues.

    Dr. Asare is a Phi Beta Kappa graduate of Randolph-Macon College in Ashland, Virginia where he was a double major in Chemistry and Biology. He subsequently received his medical education at Howard University College of Medicine, Washington, DC and was inducted into the Alpha Omega Alpha Medical Honors Society. He had his General Surgery residency training at the Medical College of Wisconsin Affiliated Hospitals in Milwaukee, WI. Dr. Asare served as a clinical scholar-in-residence with the American Joint Committee on Cancer (AJCC) during residency. He has a masters degree in health services and outcomes research from Northwestern University, Chicago, IL. Following residency, he trained in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center, Houston, TX.


    Dr. Asare’s research interests include improving cancer data quality, cancer staging, prognostication, surveillance, clinical trials and outcomes research. He practices both at the Huntsman Cancer Institute and Intermountain Healthcare Center in Murray.

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions General Surgery
    Board Certification
    American Board of Surgery (Sub: Complex General Surgical Oncology)
    American Board of Surgery (Sub: General Surgery)

    Education history

    Fellowship Complex General Surgical Oncology - University of Texas MD Anderson Cancer Center Clinical Fellow
    General Surgery - Medical College of Wisconsin Affiliated Hospitals Resident
    Graduate Training Health Services and Outcomes Research - Northwestern University Feinberg School of Medicine M.S.
    General Surgery - Medical College of Wisconsin Affiliated Hospitals Resident
    Internship General Surgery - Medical College of Wisconsin Affiliated Hospitals Intern
    Medicine - Howard University College of Medicine M.D.
    Undergraduate Biology and Chemistry (double major) - Randolph-Macon College B.S.

    Selected Publications

    Journal Article

    1. Brunsgaard EK, Bowles TL, Asare EA, Grossmann K, Boucher KM, Grossmann A, Jackson JA, Wada DA, Rathore R, Budde G, Grandemange A, Hyngstrom JR (2023). Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma. Melanoma Res, 33(3), 184-191.
    2. Asare EA, Fisher SB, Chiang YJ, Haydu LE, Patel SH, Keung EZ, Lucci A, Wargo J, Gershenwald JE, Ross MI, Lee JE (2023). Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management. J Surg Oncol.
    3. Asare EA, Brookland RK, Gershenwald JE, Nelson H, Washington MK (2023). Letter to the Editor: Re: Reimagining Cancer Staging in the Era of Evolutionary Oncology. J Natl Compr Canc Netw, 21(4), xviii.
    4. Lillemoe HA, Williams JK, Teshome MK, Zheng L, Francescatti AB, Hieken TJ, Katz MH, Hunt KH, Vreeland TJ, Asare EA (2022). Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. J Am Coll Surg, 236(2), 424-428.
    5. Pearson J, Jacobson C, Ugochukwu N, Asare E, Kan K, Pace N, Han J, Wan N, Schonberger R, Andreae M (2022). Geospatial analysis of patients' social determinants of health for health systems science and disparity research. Int Anesthesiol Clin, 61(1), 49-62.
    6. Elliot A Asare MD MS, Alisha Lussiez MD, Melissa H Watt, PhD, Charles K Dally, MD, Eileen A Micah, MBChB, Gifty Kwakye MD MPH (2022). Do you want to be told if you have cancer? A Cross-sectional Survey of Ghanaians . J Glob Health Rep, 6.
    7. Asare EA, Swami U, Stewart JH 4th (2021). Landmark Series on Disparities in Surgical Oncology: Melanoma. Ann Surg Oncol, 28, 6986-6993.
    8. Asare EA, Stewart JH 4th (2021). ASO Author Reflections: Melanoma Killed Bob Marley and Others Too. Ann Surg Oncol, 28, 6994.
    9. Bleicher J, Asare EA, Flores S, Bowles TL, Bowen GM, Hyngstrom JR (2020). Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort study. Am J Surg, 221(4), 844-849.
    10. Bleicher J, Cohan JN, Huang LC, Peche W, Pickron TB, Scaife CL, Bowles TL, Hyngstrom JR, Asare EA (2020). Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature. World J Gastroenterol, 27(3), 267-280.
    11. Bleicher J, Swords DS, Mali ME, McGuire L, Pahlkotter MK, Asare EA, Bowles TL, Hyngstrom JR (2020). Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance. J Surg Oncol, 122(8), 1770-1777.
    12. Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD (2019). Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg, 220(1), 140-146.
    13. Asare EA, Davis CH, Chiang YJ, Sabir S, Rajkot NF, Phillips PR, Roland CL, Torres KE, Hunt KK, Feig BW (2019). Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol, 121(3), 474-479.
    14. Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND (2019). Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol, 26(11), 3593-3599.
    15. Asare EA, Perrier ND (2019). ASO Author Reflections: Distant Metastatic Parathyroid Carcinoma-Has the "Train Left the Station?". Ann Surg Oncol, 26(11), 3600-3601.
    16. Nobecourt PF, Zagzag J, Asare EA, Perrier ND (2018). Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism. Front Endocrinol (Lausanne), 9, 618.
    17. Asare EA, Vreeland TJ, Feig BW (2018). Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach. Ann Surg Oncol, 25(9), 2641.
    18. Asare EA, Evans DB, Erickson BA, Aburajab M, Tolat P, Tsai S (2016). Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer. J Surg Oncol, 114(3), 291-5.
    19. Asare EA, Liu L, Hess KR, Gordon EJ, Paruch JL, Palis B, Dahlke AR, McCabe R, Cohen ME, Winchester DP, Bilimoria KY (2015). Development of a model to predict breast cancer survival using data from the National Cancer Data Base. Surgery, 159(2), 495-502.
    20. Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, Kakar S, Weiser MR, Overman MJ (2015). The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Cancer, 122(2), 213-21.
    21. Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS (2015). Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol, 22(12), 3990-5.
    22. Asare EA, Greenberg S, Szabo S, Sato TT (2014). Giant Paratubal Cyst in Adolescence: Case Report, Modified Minimal Access Surgical Technique, and Literature Review. J Pediatr Adolesc Gynecol, 28(5), e143-5.
    23. Asare EA, Gress DM, Greene FL, Winchester DP (2015). Cancer registry data: Engaging the clinician to improve quality. Cancer, 121(17), 2866-7.
    24. Asare EA, Washington MK, Gress DM, Gershenwald JE, Greene FL (2015). Improving the quality of cancer staging. CA Cancer J Clin, 65(4), 261-3.
    25. Asare EA, Wang TS (2015). Comparative effectiveness in thyroid cancer: key questions and how to answer them. Cancer Treat Res, 164, 67-87.
    26. Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C (2014). A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. Surgery, 156(6), 1378-85; discussion 1385-6.
    27. Kinnier CV, Asare EA, Mohanty S, Paruch JL, Rajaram R, Bilimoria KY (2014). Risk prediction tools in surgical oncology. J Surg Oncol, 110(5), 500-8.

    Review

    1. Janczewski LM, Browner AE, Cotler JH, Nelson H, Kakar S, Carr NJ, Hanna NN, Holowatyj AN, Goldberg RM, Washington MK, Asare EA, Overman MJ, American Joint Committee on Cancer Expert Panel on Cancers for the Lower Gastrointestinal Appendix Disease Site (2023). Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer. [Review]. CA Cancer J Clin.
    2. Janczewski LM, Faski J, Nelson H, Gollub MJ, Eng C, Brierley JD, Palefsky JM, Goldberg RM, Washington MK, Asare EA, Goodman KA, American Joint Committee on Cancer Expert Panel on Cancers of the Lower Gastrointestinal Anus Disease Site (2023). Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer. [Review]. CA Cancer J Clin.

    Edited Book

    1. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (Eds.) (2017). AJCC Cancer Staging Manual. (8th Edition). Springer International Publishing.

    Book Chapter

    1. Fisher SB, Asare EA, Habra MA, Perrier ND (2019). Chapter 16: Advances in the Diagnosis and Management of Adrenocortical Carcinoma. In Shifrin A (Ed.), Advances in Treatment and Management in Surgical Endocrinology. Elsevier.
    2. Asare EA, Evans DB, Tsai S (2019). Chapter 106. Unusual Pancreatic Tumors. In Cameron: Current Surgical Therapy (13). Elsevier.
    3. Asare EA, Wang H, Tamm EP, Mortenson MM, Evans DB, Tsai S (2019). Chapter 99: Unusual Pancreatic Tumors. In Yeo CJ, DeMeester SR, McFadden DW, Matthews JB, Fleshman JW (Eds.), Shackelford’s Surgery of the Alimentary Tract (8th Edition). Elsevier.
    4. Asare EA, Miura JT, Carr AA (2016). Adrenal Gland. In Surgery Review Illustrated (2nd edition). McGraw-Hill.
    5. Asare EA, Wang TS (2015). Comparative Effectiveness in Thyroid Cancer: Key Questions and How to Answer Them. In Bilimora KY, Minami CA, Mahvi DM (Eds.), Comparative Effectiveness in Surgical Oncology (164, pp. 67-87). Springer.

    Editorial

    1. Ge PS, Shi C, Asare E, Washington MK, OToole D (2023). EXPANDING ROLE OF GASTROENTEROLOGY IN THE STAGING OF DIGESTIVE NEUROENDOCRINE TUMORS: UPDATES FROM THE AJCC VERSION 9 CANCER STAGING SYSTEM. Clin Gastroenterol Hepatol.
    2. Asare EA, Andreae MH, Stewart JH 4th (2022). Bridging the Disparity Gap in Surgical Oncology Access: Does Telehealth Hold a Key? Ann Surg Oncol, 29(12), 7235-7236.
    3. Elliot A Asare, MD, MS, FACS (2021). NCDB-Generated Literature on Cancer Disparities.
    4. Asare EA, Grubbs EG, Gershenwald JE, Greene FL, Aloia TA (2019). Setting the "stage" for Surgical Oncology fellows: Pierre Denoix and TNM staging. J Surg Oncol, 119(7), 823.
    5. Asare EA, Feig BW (2019). Raining Frogs, Flying Horses, and Defining Tumor Rupture in GIST. Ann Surg Oncol, 26(6), 1601-1603.
    6. Asare EA, Bilimoria KY, Greene FL (2014). Beyond anatomic staging for cancer. J Surg Oncol, 111(3), 249-50.

    Letter

    1. Elliot A Asare, MD, MS (2021). Public Perceptions: The Role of Residents in Operations [Letter to the editor].
    2. Asare EA, Perrier ND (2019). Letter to the Editor: "An Analysis of the American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma". [Letter to the editor]. J Clin Endocrinol Metab, 105(9).

    Abstract

    1. Brunsgaard EK, Asare EA, Bowles TL, Hyngstrom JR (2022). Nodal surveillance and adjuvant therapy in sentinel lymph node-positive​ melanoma patients [Abstract].
    2. Davis C, Asare EA, Sabir SH, Roland CL, Torres KE, Hunt KK, Cormier JN, Feig BW (2018). Management and Outcomes of Patients with Fistulized Mesenchymal Tumors. Poster presented at the Society of Surgical Oncology 72nd Annual Cancer Symposium, San Diego, CA [Abstract]. 26, S179-80.
    3. Asare E, Vreeland T, Feig B (2018). Video abstract of a resection of a perirectal leiomyosarcoma via a posterior transcoccygeal approach with sphincter preservation. Society of Surgical Oncology 71st Annual Cancer Symposium, Chicago, IL [Abstract]. 25, S79-80.
    4. Keung E, Asare EA, Chiang YJ, Prakash L, Rajkot N, Roland CL, Torres KE, Cormier JN, Feig B, Katz MH, Lee JE, Tzeng CW (2018). Postoperative Pancreatic Fistula and Morbidity after Distal Pancreatectomy for Non-Pancreas Retroperitoneal Tumor Resection. Society of Surgical Oncology 72nd Annual Cancer Symposium, March 27-30, 2018, San Diego, CA, USA [Abstract]. Surgery (Oxf).
    5. Mizuno T, Goumard C, Okuno M, Asare EA, Krampitz GW, Aloia TA, Tzeng CWD, Chun YS, Lee JE, Vauthey JN, Nagino M, Conrad C (2018). Indocyanine green fluorescence counterstaining for anatomic laparoscopic partial splenectomy [Abstract]. 20, S41.
    6. Asare E, Compton C, Hanna N, Kakar S, Weiser M, Overman MJ (2015). The role of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Database. Poster presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, San Francisco, CA [Abstract]. 33(3_suppl), 668.
    7. Asare E, Green D, Xiang Q, Gamblin TC, Turaga K, Pappas SG, Christians KK, Quebbeman EJ, Evans DB, Knechtges P, Tsai S (2012). Low lean body mass negatively predicts completion of neoadjuvant chemotherapy among patients with resectable and borderline resectable pancreatic cancer. Oral presentation at the 12th Annual Americas Hepato-Pancreato-Biliary Association (AHPBA) Meeting, Miami, FL [Abstract].
    8. Yalowich JC, Asare E, Giorgianni A (2006). Benzoquinone -induced inhibition of DNA topoisomerase II. [Abstract]. 1300-c-01.

    Other

    1. Janet E Lindsley, PhD, Emine Ercikan Abali, PhD, Elliot A Asare, MD, MS, Marco Antonio Carvalho-Filho, MD, PhD, Candace Chow, PhD, MA, Marisol Hernandez, MLS, MA, Susan Jamieson, PhD, EdD, Amit Kaushal, MD, MScCH, Nicole N Woods, PhD (2021). Contribution of basic science to the professional identity development of medical learners: A BEME scoping review protocol. Best Evidence Medical and Health Professional Education.

    Video/Film/CD/Web/Podcast

    1. Bowles TR, Asare EA (2021). Item writer for the TWIS Soft Tissue Neoplasm, Part 2 of 2 Quiz. The SCORE Portal.  [Web].
    2. Hyngstrom JR, Asare EA (2020). Hyngstrom JR, Asare EA. Item writer for the TWIS Soft Tissue Neoplasm, Part 1 of 2 Quiz. The SCORE Portal. http://www.surgicalcore.org. [Web].
    3. Asare EA, Gershenwald JE (2018). Melanoma – Wide Excision [Web]. The SCORE Portal.
    4. Asare EA (2015). Invited by Medscape Medical News to comment on how a new study on microscopic extension will affect the future of AJCC Cancer Staging for papillary thyroid cancer. Microscopic Extension Does Not Up PTC Recurrence or Death, by Miriam E. Tucker [Web]. Medscape Medical News.